A peptide COA is a compact analytical report. Every useful line should connect an attribute of the material to a sample, a method, and a result. The document becomes weaker when those connections are missing—and no percentage, logo, or chromatogram screenshot can repair a broken sample identity.
Read a COA by turning its fields into analytical questions. Which molecule and batch were tested? Which property did the method measure? Was the result quantitative, qualitative, or a comparison with a limit?
1. Build the Sample Identity First
Collect the compound name, batch or lot number, sample code, internal laboratory code, and report identifier. They occupy different levels of the record. The batch connects data to supplier material; the sample code tracks the portion submitted; the internal code tracks laboratory custody; and the report number identifies the issued document.
Compare the batch with the physical vial and inventory entry. Then confirm that compound designations are chemically consistent, including any named form, modification, or accepted analytical synonym. If the report cannot be tied to the received material, subsequent numbers are analytically interesting but operationally unusable.
Report revision belongs in the identity chain as well. A reissued certificate may correct a batch, method, or calculation without changing the tested sample. Retain the authorized revision history and prevent an obsolete version from remaining attached to active inventory.
2. Separate Three Molecular Measurements
| Measurement | What it addresses | Typical limitation |
|---|---|---|
| Identity | Whether features match the target molecule | May not quantify the amount |
| Purity | Main component relative to detected related material | Depends on method and response |
| Assay/content | Quantity of target in a stated unit | Does not profile every impurity |
Conflating these measurements produces common errors. A 99% chromatographic area result is not the same as 99% of labeled vial mass. A molecular-mass match does not prove the stated milligrams. Each result needs its own method, units, reference basis, and acceptance criterion.
Even within one category, the result basis matters. Purity by area normalization, purity against a reference standard, and mass balance are not interchangeable calculations. The certificate or retrievable method should make the reported basis identifiable.
3. Interrogate the Method Reference
An instrument family is not a method. “HPLC” leaves open the stationary phase, mobile phase, gradient, detector, wavelength, standardization, integration rules, and selectivity. “MS” leaves open ionization, mass range, resolving power, charge interpretation, and the criteria used to accept a match.
A COA need not reproduce an entire controlled procedure, but it should identify the test well enough to retrieve its scope. If specificity is critical, examine whether the target was distinguished from structurally related peptides, degradants, formulation components, and other likely interferences. An orthogonal measurement can strengthen an assignment when one technique is not sufficiently discriminating.
System-suitability data, standards, blanks, and controls show whether the analytical run performed as intended. They may sit outside the summary page, but a technical review should be able to request and connect them to the reported sample when the decision requires that depth.
4. Put Numerical Results Against Specifications
Read the number, unit, calculation basis, and limit as one unit of information. A result of “9.8” is incomplete until the report explains whether it means milligrams per vial, milligrams per gram, percent by mass, or another quantity. A “pass” statement is similarly incomplete without the attribute and criterion behind it.
Avoid importing a fixed purity threshold from another material. Specifications should reflect the peptide, method capability, impurity knowledge, and intended research procedure. Test dates document when analysis occurred; they do not create a universal six-month or one-year validity period independent of stability and storage history.
Rounding can matter near a limit. Determine whether the displayed value is rounded from a higher-precision result and how the procedure handles borderline outcomes. A pass/fail decision should follow the controlled calculation rule rather than visual comparison of abbreviated numbers.
5. Define the Negative Space
A certificate reports selected measurements, not every possible property of the vial. If no result is listed for water, counterion, residual solvent, endotoxin, microbial burden, aggregation, or sterility, that attribute remains unreported. The correct notation is not tested or not shown—not assumed compliant.
The same distinction applies to raw outputs. A chromatogram can provide useful evidence of separation and integration, but its absence from a summary COA does not automatically invalidate the reported result. It means the summary alone cannot be used to inspect that supporting detail; request the underlying data when the protocol requires it.
6. Decide Whether the Evidence Is Fit for Purpose
Complete the review by mapping required material attributes to reported tests. Verify laboratory and report authenticity, lot match, method references, results, limits, dates, and authorization. Flag contradictions and decide whether another document or an additional analysis is necessary before the material enters the workflow.
Regulated-industry guidance is a useful model for traceable reporting, but it does not grant regulatory status to an RUO peptide. The defensible conclusion from a COA is molecular and specific: a stated sample produced stated results under stated procedures. Keeping the claim at that scale protects the quality of both the material record and the data built from it.
